About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Cardiovascular Diseases group is a translational research group within the Cardiology Department of Vall d’Hebron Hospital that performs laboratory, clinical and epidemiological research. In the CIBERCV network we are within the topic of descriptor 2 “Arterial disease, thrombosis and myocardial ischemia-reperfusion injury”. Our contributions in these topics address the following lines:
In the CIBERESP network, our group is interested in the study of effectiveness/cost-effectiveness of cardiovascular interventions, health outcome research and methods in clinical research. The group has 19 principal investigators, 32 active projects and clinical trial and has been done 142 publications in 2020.
PMID: 35321860 Journal: EuroIntervention Year: 2022 Reference: EuroIntervention. 2022 Mar 24. pii: EIJ-D-21-00891. doi: 10.4244/EIJ-D-21-00891. Impact factor: 6.534 Publication type: Paper in international publication Authors: Cobiella, Javier, Toggweiler, Stefan, Saia, Francesco, Dabrowski, Maciej, Serra, Vicent, Alfonso, Fernando, Ribeiro, Henrique B, Regueiro, Ander, Alpieri, Alberto, Gil Ongay, Aritz et al. DOI: 10.4244/EIJ-D-21-00891
PMID: 35282384 Journal: Frontiers in Cardiovascular Medicine Year: 2022 Reference: Front Cardiovasc Med. 2022 Feb 25;9:838473. doi: 10.3389/fcvm.2022.838473. eCollection 2022. Impact factor: 6.05 Publication type: Paper in international publication Authors: Francisco-Pascual, Jaume, Rivas-Gandara, Nuria, Bach-Oller, Montserrat, Badia-Molins, Clara, Maymi-Ballesteros, Manel, Benito, Begona, Perez-Rodon, Jordi, Santos-Ortega, Alba, Sambola-Ayala, Antonia, Roca-Luque, Ivo et al. DOI: 10.3389/fcvm.2022.838473
PMID: 35281755 Journal: International journal of cardiology. Heart & vasculature Year: 2022 Reference: Int J Cardiol Heart Vasc. 2022 Mar 7;39:100977. doi: 10.1016/j.ijcha.2022.100977. eCollection 2022 Apr. Impact factor: 0 Publication type: Paper in international publication Authors: Pala, Elena, Pagola, Jorge, Juega, Jesus, Francisco-Pascual, Jaume, Penalba, Anna, Rodriguez, Maite, De Lera Alfonso, Mercedes, Arenillas, Juan F, Cabezas, Juan Antonio, Moniche, Francisco et al. DOI: 10.1016/j.ijcha.2022.100977
PMID: 33833069 Journal: HEART Year: 2022 Reference: Heart. 2022 Jan;108(2):137-144. doi: 10.1136/heartjnl-2020-318907. Epub 2021 Apr 8. Impact factor: 5.994 Publication type: Paper in international publication Authors: Shanks, Miriam, Popescu, Bogdan A, Galian-Gay, Laura, Fijalkowski, Marcin, Liang, Michael, Tay, Edgar, Ajmone Marsan, Nina, Selvanayagam, Joseph B, Yeo, Tiong-Cheng, Pinto, Fausto J et al. DOI: 10.1136/heartjnl-2020-318907
PMID: 32828783 Journal: JACC-Cardiovascular Imaging Year: 2021 Reference: JACC Cardiovasc Imaging. 2021 Mar;14(3):657-665. doi: 10.1016/j.jcmg.2020.06.029. Epub 2020 Aug 19. Impact factor: 14.805 Publication type: Paper in international publication Authors: Hirschfeld, Cole B, Dondi, Maurizio, Pascual, Thomas N B, Mercuri, Mathew, Vitola, Joao, Kashyap, R, Lele, V, Magboo, V P C, Mahmarian, J J, Meeks, J B et al. DOI: 10.1016/j.jcmg.2020.06.029
PMID: 32958324 Journal: CURRENT PROBLEMS IN CARDIOLOGY Year: 2021 Reference: Curr Probl Cardiol. 2021 Mar;46(3):100654. doi: 10.1016/j.cpcardiol.2020.100654. Epub 2020 Jul 22. Impact factor: 5.2 Publication type: Review in international publication Authors: Bossone, Eduardo, Czerny, Martin, Lerakis, Stamatios, Rodriguez-Palomares, Jose, Kukar, Nina, Ranieri, Brigida, Russo, Valentina, Punzo, Bruna, Cocchia, Rosangela, Cademartiri, Filippo et al. DOI: 10.1016/j.cpcardiol.2020.100654
PMID: 34050592 Journal: EUROPEAN JOURNAL OF HEART FAILURE Year: 2021 Reference: Eur J Heart Fail. 2021 Aug;23(8):1276-1286. doi: 10.1002/ejhf.2250. Epub 2021 Jun 9. Impact factor: 15.534 Publication type: Paper in international publication Authors: Paniagua-Martin, Maria Jesus, Stojkovic, Tanya, Shomanova, Zornitsa, Bermudez-Jimenez, Francisco, Palladino, Alberto, Freimark, Dov, Garcia-Alvarez, Maria I, Jorda, Paloma, Dominguez, Fernando, Ochoa, Juan Pablo et al. DOI: 10.1002/ejhf.2250
PMID: 34032928 Journal: ACTA DIABETOLOGICA Year: 2021 Reference: Acta Diabetol. 2021 Oct;58(10):1403-1412. doi: 10.1007/s00592-021-01735-5. Epub 2021 May 25. Impact factor: 4.28 Publication type: Paper in international publication Authors: Planas, Alejandra, Simo-Servat, Olga, Baneras, Jordi, Sanchez, Monica, Garcia, Esther, Ortiz, Angel M, Ruiz-Meana, Marisol, Hernandez, Cristina, Ferreira-Gonzalez, Ignacio, Simo, Rafael et al. DOI: 10.1007/s00592-021-01735-5
PMID: 32001827 Journal: JOURNAL OF HUMAN HYPERTENSION Year: 2020 Reference: J Hum Hypertens. 2020 Mar;34(3):258. doi: 10.1038/s41371-020-0304-x. Impact factor: 2.26 Publication type: Letter or abstract Authors: Uejima, Tokuhisa, Dunstan, Frank D, Arbustini, Eloisa, Loboz-Grudzien, Krystyna, Hughes, Alun D, Carerj, Scipione, Favalli, Valentina, Antonini-Canterin, Francesco, Vriz, Olga, Vinereanu, Dragos et al. DOI: 10.1038/s41371-020-0304-x
PMID: 31130344 Journal: REVISTA ESPANOLA DE CARDIOLOGIA Year: 2020 Reference: Rev Esp Cardiol (Engl Ed). 2020 Feb;73(2):131-138. doi: 10.1016/j.rec.2019.02.014. Epub 2019 May 24. Impact factor: 4.642 Publication type: Paper in national publication Authors: Galian-Gay, Laura, Gordon, Blanca, Marsal, Josep Ramon, Rafecas, Agnes, Pijuan Domenech, Antonia, Castro, Miguel Angel, Sureda, Carlos, Miranda, Berta, Marti, Gerard, Garcia-Dorado, David et al. DOI: 10.1016/j.recesp.2019.02.020
PMID: 31992059 Journal: Circulation-Cardiovascular Interventions Year: 2020 Reference: Circ Cardiovasc Interv. 2020 Feb;13(2):e008620. doi: 10.1161/CIRCINTERVENTIONS.119.008620. Epub 2020 Jan 29. Impact factor: 5.493 Publication type: Paper in international publication Authors: Serra, Vicenc, Alperi, Alberto, Nombela-Franco, Luis, Fischer, Quentin, Veiga, Gabriela, Donaint, Pierre, Asmarats, Lluis, Vilalta, Victoria, Chamandi, Chekrallah, Regueiro, Ander et al. DOI: 10.1161/CIRCINTERVENTIONS.119.008620
PMID: 31981616 Journal: European Journal of Medical Genetics Year: 2020 Reference: Eur J Med Genet. 2020 Apr;63(4):103854. doi: 10.1016/j.ejmg.2020.103854. Epub 2020 Jan 23. Impact factor: 2.368 Publication type: Letter or abstract Authors: Blasco-Lucas, Arnau, Maldonado, Giuliana, Amador-Catalan, Amaya, Ferrer-Curriu, Gemma, Fuste, Berta, Perez, Maria L, Gonzalez-Alujas, Teresa, Beltran, Sergi, Comas-Riu, Jaume, Bardaji, Alfredo et al. DOI: 10.1016/j.ejmg.2020.103854
The consensus document is the result of multidisciplinary work that takes into account the risks associated with all stages of women's lives and the differences compared to men.
The study, which involved Vall d'Hebron, developed an action plan to efficiently allocate resources to patients most at risk of suffering this complication.
In light of this evidence, hospitals such as Vall d'Hebron have already started to include warnings about environmental pollution in their hospital discharge plans after a myocardial infarction.
